Literature DB >> 33155041

High Thoracic Erector Spinae Plane Block for Arthroscopic Shoulder Surgery: A Randomized Prospective Double-Blind Study.

Bahadir Ciftci1, Mursel Ekinci1, Birzat Emre Gölboyu2, Furkan Kapukaya1, Yunus Oktay Atalay1, Ersin Kuyucu3, Yavuz Demiraran1.   

Abstract

OBJECTIVE: Moderate to severe pain may occur following arthroscopic shoulder surgery. An erector spinae plane block (ESPB) may be used for painful conditions of the shoulder. The primary hypothesis of this trial is that ultrasound-guided ESPB would provide effective analgesia by reducing opioid consumption. The secondary hypothesis is that ESPB would result in low pain scores and reduce the use of rescue analgesia.
DESIGN: Randomized prospective double-blind study.
SETTING: Academic university hospital.
SUBJECTS: Sixty patients aged between 18 and 65 years designated as American Society of Anesthesiologists (ASA) class I or II who underwent unilateral arthroscopic shoulder surgery under general anesthesia were included in the study.
METHODS: Patients were equally divided into two groups-either the ESPB group (n=30) or the sham block group (n=30). ESPB was performed with 30 mL 0.25% bupivacaine at the T2 level in the ESPB group and sham block with 30 mL saline at the T2 level in the sham block group. Twenty minutes before the end of the operation, 100 mg tramadol was administered intravenously to the patients. Intravenous ibuprofen 400 mg 3 × 1 was ordered for the patients during the postoperative period. A patient control analgesia device including a dose of 10 µg/mL fentanyl was connected to the patients.
RESULTS: There were no statistical differences between groups in terms of demographical data. Postoperative fentanyl consumption was significantly lower in the ESPB group than in the sham block group (96.66 µg ±105.57 µg and 230 µg ±247.17 µg, respectively) (P=0.009). The need for rescue analgesia was significantly lower in the ESPB group than in the sham block group (26.66 mg ±35.43 mg and 48.5 mg ±35.45 mg, respectively) (P=0.020). Overall, the visual analog scale scores were significantly lower in the ESPB group than in the sham block group.
CONCLUSIONS: ESPB may provide effective analgesia treatment following arthroscopic shoulder surgery.
© The Author(s) 2020. Published by Oxford University Press on behalf of the American Academy of Pain Medicine. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Arthroscopic Shoulder Surgery; Erector Spinae Plane Block; Postoperative Analgesia

Mesh:

Year:  2021        PMID: 33155041     DOI: 10.1093/pm/pnaa359

Source DB:  PubMed          Journal:  Pain Med        ISSN: 1526-2375            Impact factor:   3.750


  4 in total

1.  Randomized Comparative Study Between Bilateral Erector Spinae Plane Block and Transversus Abdominis Plane Block Under Ultrasound Guidance for Postoperative Analgesia After Total Abdominal Hysterectomy.

Authors:  Usha Shukla; Urvashi Yadav; Amit K Singh; Abhishek Tyagi
Journal:  Cureus       Date:  2022-05-22

Review 2.  The Effect of Single-Shot Erector Spinae Plane Block (ESPB) on Opioid Consumption for Various Surgeries: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Yu Cui; Yu Wang; Jing Yang; Longqing Ran; Qianqian Zhang; Qinghua Huang; Tianqing Gong; Rong Cao; Xiao Yang
Journal:  J Pain Res       Date:  2022-03-06       Impact factor: 3.133

3.  Erector spinae plane block vs interscalene brachial plexus block for postoperative analgesia management in patients who underwent shoulder arthroscopy.

Authors:  Furkan Kapukaya; Mursel Ekinci; Bahadir Ciftci; Yunus Oktay Atalay; Birzat Emre Gölboyu; Ersin Kuyucu; Yavuz Demiraran
Journal:  BMC Anesthesiol       Date:  2022-05-12       Impact factor: 2.376

4.  Network Meta-Analysis of Perioperative Analgesic Effects of Different Interventions on Postoperative Pain After Arthroscopic Shoulder Surgery Based on Randomized Controlled Trials.

Authors:  Wu Jiangping; Quan Xiaolin; Shu Han; Xiaolan Zhou; Nie Mao; Deng Zhibo; Gong Ting; Hu Shidong; Li Xiangwei; Yuan Xin; Shu Guoyin
Journal:  Front Med (Lausanne)       Date:  2022-07-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.